Generics Industry Hungry For More After Showing Larger GLP-1 Appetite In 2024

Sandoz, Viatris Look To Be In Commercial Vanguard; Supply Core, CDMOs Vital

 
• By Dean Rudge
  
Generics producers are keen for a piece of the GLP-1 pie

More from Strategy

More from Generics Bulletin Perspectives